ADRB2 and head and neck squamous cell carcinoma: Perhaps due to the global epidemiology of OSCC (higher prevalence in Asia and South East Asia compared to North America or Europe), the prognostic significance of ADRB2 expression in North American or European HNSCC patients has not been reported.